Companies
Discover all trending biotech companies
Loading companies...
United Therapeutics Corporation
Company Research Platform
Annual Revenue
$ 794,400,000
Global Employees
1,168
R&D Investment
347100000
Business Segments
Remodulin
Comprehensive remodulin operations including research, development, and commercialization activities. This segment focuses on innovative approaches and solutions within the remodulin field, leveraging advanced technologies and expertise to address unmet medical needs and improve patient outcomes.
Orenitram
Comprehensive orenitram operations including research, development, and commercialization activities. This segment focuses on innovative approaches and solutions within the orenitram field, leveraging advanced technologies and expertise to address unmet medical needs and improve patient outcomes.
Tyvaso
Comprehensive tyvaso operations including research, development, and commercialization activities. This segment focuses on innovative approaches and solutions within the tyvaso field, leveraging advanced technologies and expertise to address unmet medical needs and improve patient outcomes.